Overview Fundamentals API Earnings EOD API Sample Code Pricing

Voyager Therapeutics Inc (VYGR NASDAQ) stock market data APIs

$5.75 -0.08(-1.4%) as of December 26, 2024
Price chart is built with Anychart

Voyager Therapeutics, Inc., a biotechnology company, focuses on the treatment of gene therapy and neurology diseases. The company's lead clinical candidate is VY-TAU01, an anti-tau antibody program for the treatment of alzheimer's disease. Its product pipeline includes superoxide dismutase 1 silencing gene therapy, which is in preclinical trial for the treatment of amyotrophic lateral sclerosis; tau silencing gene therapy, which is in preclinical trial for the treatment of alzheimer's disease; and vectorized anti-amyloid antibody, a gene therapy targeting anti-amyloid for the treatment of alzheimer's disease and is in preclinical trial. In addition, the company develops VY-FXN01, which is in preclinical trial to treat friedreich's ataxia; and GBA1 gene replacement to treat parkinson's disease and is in preclinical trial. Further, it provides research program for the treatment of Huntington's disease. The company has collaboration and license agreements with Alexion; AstraZeneca Rare Disease; Novartis Pharma AG; Neurocrine Biosciences, Inc; and Sangamo Therapeutics, Inc. Voyager Therapeutics, Inc. was incorporated in 2013 and is headquartered in Lexington, Massachusetts.

Voyager Therapeutics Inc Financial Data Overview

5.83
5.75
-
5.815
5.66
5.19-11.72
316 M
8.7576
54 626 K
164 M
-0.16
0.889
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'VYGR',
Type: 'Common Stock',
Name: 'Voyager Therapeutics Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG005ZSY233',
ISIN: NULL,
CUSIP: NULL,
CIK: '1640266',
EmployerIdNumber: '46-3003182',
FiscalYearEnd: 'December',
IPODate: '2015-11-11',
InternationalDomestic: 'Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,
}

Voyager Therapeutics Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 164 M
  • EBITDA 14 130 K
  • Earnings Per Share 0.66
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Voyager Therapeutics Inc Earnings via APIs

  • Latest Release 2024-11-04
  • EPS/Forecast -0.45

Get Voyager Therapeutics Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?
support@eodhistoricaldata.com
Chat